Current and Future Drug Targets in Weight Management
Open Access
- 23 December 2010
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 28 (8), 1792-1818
- https://doi.org/10.1007/s11095-010-0341-1
Abstract
No abstract availableKeywords
This publication has 158 references indexed in Scilit:
- The tempted brain eats: Pleasure and desire circuits in obesity and eating disordersBrain Research, 2010
- Peptide YY Is Critical for Acylethanolamine Receptor Gpr119-Induced Activation of Gastrointestinal Mucosal ResponsesCell Metabolism, 2010
- MSI-1436 reduces acute food intake without affecting dopamine transporter activityPharmacology Biochemistry and Behavior, 2010
- Central and Peripheral Molecular Targets for Antiobesity PharmacotherapyClinical Pharmacology & Therapeutics, 2010
- Biochemical effects of SIRT1 activatorsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- AMPK and PPARδ Agonists Are Exercise MimeticsCell, 2008
- The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesityPharmacology Biochemistry and Behavior, 2008
- From a glucocentric to a lipocentric approach towards metabolic syndromeDrug Discovery Today, 2008
- Human gut microbes associated with obesityNature, 2006